The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Why Rheumatologists Should Join the AMA

Why Rheumatologists Should Join the AMA

October 14, 2015 • By Gary Bryant, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Digital Storm/shutterstock.com

Image Credit: Digital Storm/shutterstock.com

Editor’s note: Welcome to the first installment of Experiences in Advocacy, a special series authored by ACR members detailing personal experiences in advocacy.

You Might Also Like
  • ACR Seeks Members’ Help to Boost AMA Representation
  • Maintain Rheumatology’s Seat at the AMA Table
  • Pointers for Rheumatologists Considering AMA Membership
Explore This Issue
October 2015

We need rheumatologists to join the American Medical Association (AMA). Here’s why, and how to do it.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Having participated in your delegation for over a decade, I have seen major improvements in focus, prioritization of issues, transparency, collaboration and diversity in the AMA, and we need your help now to keep rheumatology’s seat at the table. You can help by renewing your membership in or joining the AMA. Call the AMA at 800-262-3211, and specify that you want to join or renew for 2015. If you haven’t been an AMA member for more than a year, you can even get a half-dues discount.

Our participation in the House of Delegates (HOD) gives us a seat at the table for the Relative Value Scale Update Committee (RUC) and other vital decision-making and informational aspects of organized medicine. Despite being a relatively small subspecialty, the ACR is able to make things happen at the AMA HOD, the AMA’s policymaking meeting, through our partnerships and nimble approach to advancing issues important to rheumatologists, their practices and patients.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

The most recent AMA HOD meeting was held this summer in Chicago. Your AMA membership translates into results for you—because rheumatologists have a seat at the table. Some of the major topics discussed and actions taken are:

Great work was done by my colleagues Colin Edgerton, MD (alternate delegate), Cristina Arriens, MD (Young Physician Delegate), and Erin Mary Bauer, MD, who for the first time brought an ACR voice to the Resident and Fellows Section of the AMA.

ICD-10: The HOD adopted policy that the AMA would ask CMS and other payers for a safe harbor “grace period” for the ICD‑10 transition, based on existing policy the ACR and partners put in at previous meetings. Additionally, the AMA would aggressively promote this implementation compromise to Congress and CMS (this was new, inserted after testimony and the amendment offered by the ACR and others).

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

As you know, mitigating the burdens and risks of ICD-10 implementation has been a major focus of the ACR’s advocacy efforts, specifically with regard to legislation introduced by Rep. Diane Black (R-TN-06), H.R. 2247. The House moved this bill up the agenda in order to start the updated advocacy campaign with letters to Congress and continued efforts with CMS. This led to the joint announcement by the AMA and CMS in early July of additional flexibility in the claims auditing and quality reporting process as the medical community gains experience using the new ICD‑10 code set, which was based in large part on the legislation the ACR supported.

Pages: 1 2 3 4 | Single Page

Filed Under: Legislation & Advocacy, Professional Topics Tagged With: AC&R, Advocacy, AMA, American College of Rheumatology, American Medical Association, Professional Matters, rheumatologists, rheumatologyIssue: October 2015

You Might Also Like:
  • ACR Seeks Members’ Help to Boost AMA Representation
  • Maintain Rheumatology’s Seat at the AMA Table
  • Pointers for Rheumatologists Considering AMA Membership
  • AMA House of Delegates Meeting: Decisions Affecting You

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)